Gen, the global parent firm of cyber safety brands Norton and Avast, will pay $82 per share in cash to add the consumer ...
New data reinforces findings from MINDACT supporting MammaPrint® in predicting chemotherapy benefit for distant recurrence free interval among patients with HR+HER2-early-stage breast cancer IRVINE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback